New Report Available: Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2013
Global Markets Direct's, 'Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Chemotherapy Induced Peripheral Neuropathy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Chemotherapy Induced Peripheral Neuropathy. Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's...
View full press release